International Assets Investment Management LLC Sells 238,040 Shares of Cardinal Health, Inc. (NYSE:CAH)

International Assets Investment Management LLC lessened its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 95.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,838 shares of the company's stock after selling 238,040 shares during the quarter. International Assets Investment Management LLC's holdings in Cardinal Health were worth $1,282,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Birch Capital Management LLC boosted its holdings in shares of Cardinal Health by 1.5% in the 4th quarter. Birch Capital Management LLC now owns 28,822 shares of the company's stock valued at $3,409,000 after buying an additional 429 shares during the period. Insight Wealth Strategies LLC increased its stake in shares of Cardinal Health by 1.6% during the fourth quarter. Insight Wealth Strategies LLC now owns 19,796 shares of the company's stock valued at $2,341,000 after acquiring an additional 313 shares during the period. CWA Asset Management Group LLC raised its holdings in Cardinal Health by 10.1% during the fourth quarter. CWA Asset Management Group LLC now owns 129,052 shares of the company's stock worth $15,263,000 after purchasing an additional 11,847 shares in the last quarter. Pensionfund Sabic lifted its holdings in shares of Cardinal Health by 42.0% in the fourth quarter. Pensionfund Sabic now owns 14,200 shares of the company's stock valued at $1,679,000 after buying an additional 4,200 shares during the period. Finally, Nordea Investment Management AB boosted its stake in Cardinal Health by 6.0% during the fourth quarter. Nordea Investment Management AB now owns 22,372 shares of the company's stock valued at $2,659,000 after buying an additional 1,259 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Up 1.0 %

Cardinal Health stock traded up $1.16 during mid-day trading on Thursday, hitting $122.56. 2,261,854 shares of the company's stock were exchanged, compared to its average volume of 2,325,971. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $126.23. The stock has a 50 day moving average of $119.77 and a two-hundred day moving average of $110.84. The stock has a market cap of $29.66 billion, a P/E ratio of 23.84, a P/E/G ratio of 1.47 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The business had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. During the same period last year, the business earned $1.73 EPS. The firm's revenue was down 4.3% compared to the same quarter last year. As a group, research analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend is Thursday, January 2nd. Cardinal Health's dividend payout ratio (DPR) is 39.30%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on CAH shares. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a research report on Monday, November 4th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $130.00 to $144.00 in a research report on Wednesday. Argus boosted their price objective on Cardinal Health from $115.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, September 11th. Morgan Stanley raised their target price on shares of Cardinal Health from $127.00 to $136.00 and gave the stock an "overweight" rating in a report on Tuesday, December 17th. Finally, Mizuho began coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $139.00 price objective for the company. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $131.71.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.